Aims & Scope

The Journal of Prebiotic and Probiotic Diseases (JPPD) aims to advance research on microbiome science and microbiota-targeted interventions that improve human health and disease management.

The journal welcomes submissions in, but not limited to, the following areas:

• Prebiotics, Probiotics, Symbiotic, and Postbiotics
• Gut Microbiome and Human Health
• Host–Microbiota Interactions
• Gastrointestinal Diseases and Digestive Health
• Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS)
• Metabolic Disorders, Obesity, and Diabetes
• Immunology and Immune Modulation
• Microbiome-Based Therapeutics
• Functional Foods and Nutritional Interventions
• Microbial Ecology and Microbiome Science
• Antibiotic-Associated Disorders and Antimicrobial Resistance
• Neurogastroenterology and the Gut–Brain Axis
• Microbiome and Mental Health
• Pediatric and Geriatric Microbiome Research
• Precision Nutrition and Personalized Medicine
• Clinical Trials and Translational Microbiome Research
• Molecular Mechanisms of Microbiota Function
• Food Science, Fermentation, and Bioactive Compounds
• Public Health Applications of Microbiome Research
• Emerging Technologies in Microbiome Analysis

The journal particularly encourages studies that demonstrate clinical relevance, translational value, therapeutic innovation, and evidence-based approaches to microbiome-targeted healthcare.
 

The journal seeks to:

• Promote high-quality research on prebiotics, probiotics, synbiotics, postbiotics, and microbiome science.
• Advance understanding of host–microbiota interactions and their role in health and disease.
• Encourage translational and clinical research that supports microbiome-based diagnostics, prevention, and therapies.
• Foster innovation in functional nutrition, personalized medicine, and microbiota-targeted healthcare interventions.
• Support research addressing gastrointestinal, metabolic, immune, and neurological disorders associated with microbiome imbalance.
• Promote evidence-based approaches to microbiome modulation and therapeutic development.
• Encourage interdisciplinary collaboration among researchers, clinicians, nutrition scientists, and healthcare professionals.
• Provide an open-access platform for the global dissemination of impactful microbiome and health research.